- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06812845
Patterns of Eye Diseases Among Patients Attending The Eye Investigation Unit of Sohag University Hospital
The goal of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.organize the community education. The main question it aims to answer is
- DOES eye disease blindness prevalence rate increase in women more than men?
- What is the rate of glaucoma and other ocular diseases that causes irreversible blindness among the attending patients? Patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025 are being observed in this work to determine the eye diseases prevalence.
Study Overview
Detailed Description
This type of study is helpful to get an idea about the epidemiology of ocular disorders. It is necessary to organize the community education and ensure early treatment to reduce the prevalence of such diseases in the general population.
- Aim of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.
- Study design: observational Cross-Sectional study.3
- Patients and methods: all patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025.
- Inclusion criteria: All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.
Exclusion criteria:
- Patients unable to measure visual acuity.
- Patients unable to measure intraocular pressure.
- Mentally retarded patients.
- Undiagnosed patients.
Time schedule:
- Twelve months for collection of data, writing the review of literature and methodology.
- Three months for analysis of data and writing the results.
- Three months for writing the discussion and conclusions.
ethical considerations:
- The study adheres to Tents of Helsinki declaration.
- The study will be approved by the ethical committee of the faculty of medicine Sohag University.
- An informed written consent will be taken from all of the participants in the study or their guardians
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: mahmoud AE Dr\ mahmoud abdelwareth
- Phone Number: 093 01150969875
- Email: Mahmoud_abdelwareth_post@med.sohag.edu.eg
Study Contact Backup
- Name: mortada AH Prof\ abuzaid, Professor
- Phone Number: 093 01203324446
Study Locations
-
-
-
Sohag, Egypt, 82524
- Recruiting
- Faculty of Medicine in Sohag University
-
Contact:
- mahmoud AE DR\ abdelwareth mohamed
- Phone Number: 093 01150969875
- Email: Mahmoud_abdelwareth_post@med.sohagedu.eg
-
Contact:
- Mortada AH Prof\ Abozaid, professor
- Phone Number: 093 01203324446
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.
Exclusion Criteria:
- Patients unable to measure visual acuity.
- Patients unable to measure intraocular pressure.
- Mentally retarded patients.
- Undiagnosed patients.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
determine the pattrens of eye diseases among patients attending the eye investigtion unit of sohag university
Time Frame: 1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.
|
recording data of the prevalence of each eye disease among the study group in the period from January 2025 to December 2025 .their
percentage in men and women , also in which age group
|
1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: mortada AH Prof\ abuzaid, Professor, depatement of ophthalmology ,sohag university
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med--25-1-10MS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Diseases
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
The General Authority for Teaching Hospitals and...Recruiting
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
Dompé Farmaceutici S.p.ACompletedDry Eye DiseaseUnited States, Italy
-
Neuro-Ophthalmology of TexasHarrow IncRecruiting
-
Vision Innovation Centers of Pennsylvania, LLC...Nordic Pharma, USARecruiting
-
Demaod LtdNot yet recruitingDry Eye | Dry Eye Syndromes
Clinical Trials on eye investigations
-
Saint-Joseph UniversityUnknownMultiple Sclerosis | Urinary Bladder, Neurogenic | UrodynamicsLebanon
-
Medical University of ViennaRecruitingViral Myocarditis | POTS | Post Viral FatigueAustria
-
Institut de cancérologie Strasbourg EuropeCompletedVaginal Cancer | Prostate Carcinoma | Radiotherapy | Rectum Carcinoma | Cervix Carcinoma | Anal Canal Carcinoma | Endometrium CarcinomaFrance
-
Sahlgrenska University Hospital, SwedenUnknownCardiac Allograft Vasculopathy | Graft Dysfunction | Chronic Rejection of Cardiac TransplantSweden
-
Association pour le Développement et l'Organisation...National Research Agency, France; NRJ Foundation - Institute of FranceCompletedHealthy | REM Sleep Behavior DisorderFrance
-
Sohag UniversityActive, not recruitingDiabetes Mellitus, Type 2Egypt
-
Nantes University HospitalCompleted
-
Assiut UniversityCompletedMultiple Sclerosis Acute and ProgressiveEgypt
-
Direction Centrale du Service de Santé des ArméesRecruitingOtotoxicity, Drug-InducedFrance
-
Sohag UniversityNot yet recruitingImmune Thrombocytopenic Purpura